Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract
Clinical trial NCT03051373 · COMPLETED
Trial details
- NCT number
- NCT03051373
- Sponsor
- Chinese PLA General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-01
- Primary completion
- 2019-04-30
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.